Literature DB >> 19545560

Autoradiographic comparison of in vitro binding characteristics of various tritiated adenosine A2A receptor ligands in rat, mouse and pig brain and first ex vivo results.

Wiebke Sihver1, Annette Schulze, Walter Wutz, Stefan Stüsgen, Ray A Olsson, Dirk Bier, Marcus H Holschbach.   

Abstract

The adenosine A(2A) receptor in the basal ganglia is involved in the control of movement and plays a role in movement disorders such as Parkinsonism. Developing ligands to evaluate that receptor by noninvasive methods such as positron emission tomography has a high priority. In vitro radioligand binding guides the selection of ligands for in vivo application. This study measured the binding of the adenosine A(2A) receptor antagonist [(3)H]MSX-2 (3-(3-hydroxypropyl)-8-m-methoxystyryl)-7-methyl-1-propargylxanthine) to rat, mouse and pig brain by autoradiography. Other studies measured binding to membranes from PC12 pheochromocytoma cells. Those binding parameters were compared to those of the adenosine A(2A) receptor antagonist [(3)H]ZM241385 (4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino)ethyl)phenol), the adenosine A(2A) receptor agonist [(3)H]CGS21680 (2-[p-(2-carboxyethyl)-phenethylamino]-5'-N-ethylcarboxamidoadenosine) and the unselective adenosine receptor agonist [(3)H]NECA (5'N-ethylcarboxamido)adenosine). The potency order (K(d)) in the three species was [(3)H]ZM241385<[(3)H]MSX-2<[(3)H]NECA<[(3)H]CGS21680. The density of [(3)H]MSX-2 binding sites was greater in the striatum than in the cortex. Preliminary ex vivo experiments showed that by 10min after iv injection, [(3)H]MSX-2 and [(3)H]CGS21680 crossed the blood-brain barrier to the extent of almost 1% ID/g brain tissue, but [(3)H]NECA and [(3)H]ZM241385 to only 0.2% ID/g. The prior administration of unlabeled ZM241385 significantly lowered brain uptake of [(3)H]MSX-2. In conclusion, [(3)H]MSX-2 has a high affinity and sufficient selectivity for the adenosine A(2A) receptor. It penetrates the blood-brain barrier. Sensitivity to photoisomerization is a limitation. Further investigations assess its suitability as a ligand for imaging the brain adenosine A(2A) receptor.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545560     DOI: 10.1016/j.ejphar.2009.06.025

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Selectivity is species-dependent: Characterization of standard agonists and antagonists at human, rat, and mouse adenosine receptors.

Authors:  Mohamad Wessam Alnouri; Stephan Jepards; Alessandro Casari; Anke C Schiedel; Sonja Hinz; Christa E Müller
Journal:  Purinergic Signal       Date:  2015-07-01       Impact factor: 3.765

2.  Quantitation of the A2A Adenosine Receptor Density in the Striatum of Mice and Pigs with [18F]FLUDA by Positron Emission Tomography.

Authors:  Daniel Gündel; Magali Toussaint; Thu Hang Lai; Winnie Deuther-Conrad; Paul Cumming; Susann Schröder; Rodrigo Teodoro; Rareş-Petru Moldovan; Francisco Pan-Montojo; Bernhard Sattler; Klaus Kopka; Osama Sabri; Peter Brust
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-22

3.  Improved in vivo PET imaging of the adenosine A2A receptor in the brain using [18F]FLUDA, a deuterated radiotracer with high metabolic stability.

Authors:  Thu Hang Lai; Magali Toussaint; Winnie Deuther-Conrad; Peter Brust; Rodrigo Teodoro; Sladjana Dukić-Stefanović; Daniel Gündel; Friedrich-Alexander Ludwig; Barbara Wenzel; Susann Schröder; Bernhard Sattler; Rareş-Petru Moldovan; Björn H Falkenburger; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-02       Impact factor: 9.236

4.  Effects of intra-accumbal or intra-prefrontal cortex microinjections of adenosine 2A receptor ligands on responses to cocaine reward and seeking in rats.

Authors:  K Wydra; A Suder; M Frankowska; D O Borroto Escuela; K Fuxe; M Filip
Journal:  Psychopharmacology (Berl)       Date:  2018-11-13       Impact factor: 4.530

5.  PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinson's Disease with [18F]FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy.

Authors:  Susann Schröder; Thu Hang Lai; Magali Toussaint; Mathias Kranz; Alexandra Chovsepian; Qi Shang; Sladjana Dukić-Stefanović; Winnie Deuther-Conrad; Rodrigo Teodoro; Barbara Wenzel; Rareş-Petru Moldovan; Francisco Pan-Montojo; Peter Brust
Journal:  Molecules       Date:  2020-04-02       Impact factor: 4.411

Review 6.  Molecular probes for the human adenosine receptors.

Authors:  Xue Yang; Laura H Heitman; Adriaan P IJzerman; Daan van der Es
Journal:  Purinergic Signal       Date:  2020-12-12       Impact factor: 3.765

7.  Development of 18F-Labeled Radiotracers for PET Imaging of the Adenosine A2A Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation.

Authors:  Thu Hang Lai; Susann Schröder; Magali Toussaint; Sladjana Dukić-Stefanović; Mathias Kranz; Friedrich-Alexander Ludwig; Steffen Fischer; Jörg Steinbach; Winnie Deuther-Conrad; Peter Brust; Rareş-Petru Moldovan
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

Review 8.  Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.

Authors:  Stuart P McCluskey; Christophe Plisson; Eugenii A Rabiner; Oliver Howes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-21       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.